REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 352.00
Bid: 352.00
Ask: 356.00
Change: -3.00 (-0.85%)
Spread: 4.00 (1.136%)
Open: 356.00
High: 357.00
Low: 349.00
Prev. Close: 355.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 38.5 (EPT/RI)

22 Sep 2022 10:03

RNS Number : 3129A
Citigroup Global Markets Limited
22 September 2022
 

 

FORM 38.5(a) (EPT/RI)

 

IRISH TAKEOVER PANEL

 

DEALING DISCLOSURE UNDER RULE 38.5(a) OF THE IRISHTAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022BY A CONNECTED EXEMPT PRINCIPAL TRADER WITHRECOGNISED INTERMEDIARY STATUS AND DEALING INA CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bank of Cyprus Holdings plc

(c) Name of the party to the offer with which exempt principal trader is connected: (Note 1)

Lone Star Funds XI BidCo Limited

(d) Date dealing undertaken:

21 September 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 N/A

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (Note 2)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

Ap35

 

(a) Purchases and sales

 

Class of relevant security (Note 3)

Purchases/ sales

Totalnumber of securities

Highest price per unit paid/ received (GBP)

Lowest price per unit paid/ received (GBP)

€0.10 ordinary shares

Purchase

25,532

1.3550

1.2750

€0.10 ordinary shares

Sale

25,532

1.3550

1.2750

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities (Note 4)

Price perunit (Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 4)

Exercise price per unit

Type  e.g. American, European etc.

Expirydate

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise priceper unit (Note 5)

 

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

Ap36

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

Date of disclosure:

 22 September 2022

Contact name:

Christopher Alexander Pollock

Telephone number:

028 95 954053

 

Public disclosures under Rule 38 of the Rules must be made to a Regulatory Information Service.

 

Ap37

 

NOTES ON FORM 38.5(a)

 

1. See the definition of "connected principal trader" in Rule 2.2 of Part A of the Rules.

 

2. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

 

4. See Rule 2.5(d) of Part A of the Rules.

 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

 

6. If details included in a disclosure under Rule 38 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

 

For full details of disclosure requirements, see Rules 8 and 38 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEEANNAAEDAEEA
Date   Source Headline
27th Aug 20197:05 amRNSChanges in Group organisational structure
27th Aug 20197:00 amRNS1H2019 Announcement for the Investor Presentation
27th Aug 20197:00 amRNSGroup Financial Results 6M2019
12th Aug 20198:02 amRNSNotice of Results 1H2019
5th Aug 20194:36 pmRNSPrice Monitoring Extension
8th Jul 201912:41 pmRNSTR-1 Notification of Major Holding-TD Asset Manag.
5th Jul 201912:31 pmRNSPDMR Notification of Transaction - Arapoglou
5th Jul 20199:59 amRNSTR-1 Notification of Major Holding-TD Asset Manag.
4th Jul 20198:39 amRNSPDMR Notification of Transaction - Arapoglou
3rd Jul 20193:55 pmRNSTR-1 Notification of Major Holding- Caius Capital
3rd Jul 20199:42 amRNSDirector/PDMR Shareholding-Arapoglou
2nd Jul 20191:31 pmRNSDirector/PDMR Shareholding-Arapoglou
28th Jun 20192:13 pmRNSFurther re (Completion of Project Helix)
13th Jun 201911:01 amRNSStandard Form TR-1 Caius Capital
13th Jun 20199:20 amRNSElection of Chairman
4th Jun 20197:30 amRNSAgreement for the sale of investment in CNP Cyprus
14th May 20193:06 pmRNSDirectorate Change
14th May 20192:56 pmRNSResult of AGM 2019
13th May 20194:42 pmRNSAppointment of Group Chief Executive Officer
13th May 20194:10 pmRNSDoc re. (1Q2019 FR Investor Presentation)
13th May 20193:52 pmRNS1st Quarter Results 2019
3rd May 20198:31 amRNSNotice of Results 1Q2019
10th Apr 20199:31 amRNSNotice of AGM
3rd Apr 201910:32 amRNSPillar 3 Disclosures for the year 2018
28th Mar 20192:43 pmRNSBOC Annual Financial Report 2018
28th Mar 20192:42 pmRNSBOCH Annual Financial Report 2018
28th Mar 20191:48 pmRNSGroup Financial Results FY2018
28th Mar 20191:43 pmRNSDoc re. (Investor Presentation FY2018)
27th Mar 20192:17 pmRNSDirector/PDMR Shareholding- Josef Ackermann
19th Mar 20193:16 pmRNSUpdate on Project Helix
15th Mar 201912:55 pmRNSNotice of Results - Audited FY2018 FS
4th Mar 20198:17 amRNSInvestor Presentation Announcement Prel FY2018 FR
4th Mar 20197:13 amRNSNotice of Resignation of Group CEO
4th Mar 20197:00 amRNSPreliminary FY2018 Group Financial Results
26th Feb 201912:14 pmRNSChanges in the Board Composition
19th Feb 20196:17 pmRNSAnnouncement
14th Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Jan 20197:03 amRNSResignation of Board Member
27th Dec 20189:52 amRNSIssuance of Additional Tier 1 Capital Securities
21st Dec 20184:35 pmRNSPrice Monitoring Extension
19th Dec 20182:48 pmRNSIssuance of Additional Tier 1 Capital Securities
18th Dec 20184:40 pmRNSSecond Price Monitoring Extn
18th Dec 20184:35 pmRNSPrice Monitoring Extension
14th Dec 20185:32 pmRNSEU-wide Transparency Exercise 2018
14th Dec 20187:00 amRNSAdditional Tier 1 Capital Securities
29th Nov 201810:39 amRNSPDMR Shareholding
26th Nov 20186:27 pmRNSDoc re. (Investor Presentation 9M2018 FR)
26th Nov 20185:33 pmRNS3rd Quarter Results
26th Nov 20185:28 pmRNSDoc re. (Investor Presentation 9M2018 FR)
23rd Nov 20183:40 pmRNSCompletion of the sale of Bank of Cyprus UK Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.